UroGen Pharma Ltd. (URGN)
9.34
-0.12 (-1.27%)
At close: Mar 03, 2025, 12:26 PM
UroGen Pharma Ltd. Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Cash & Equivalents | 95M | 55.41M | 44.36M | 103.91M | 49.69M | 101.32M | 37M | 21.36M | 17.98M | 3.87M | 3.04M |
| Short-Term Investments | 41.97M | 44.56M | 44.78M | 49.15M | 97.39M | n/a | 36M | n/a | n/a | n/a | n/a |
| Long-Term Investments | 4.5M | 223K | 675K | 1.89M | 48.55M | 51K | 29K | 24K | n/a | n/a | n/a |
| Other Long-Term Assets | 2.26M | 2.74M | 1.53M | 289K | 487K | 317K | 244K | 250K | n/a | n/a | n/a |
| Receivables | 15.44M | 12.7M | 11.72M | 7.05M | n/a | n/a | n/a | 83K | n/a | n/a | n/a |
| Inventory | 5.67M | 4.33M | 4.83M | 1.96M | n/a | n/a | 316K | 105K | n/a | n/a | n/a |
| Other Current Assets | 11.1M | 11.91M | 8.7M | 4.59M | 1.56M | 925K | 1.16M | 491K | 1.16M | 418K | 111K |
| Total Current Assets | 169.19M | 128.91M | 114.39M | 115.62M | 148.63M | 102.24M | 74.47M | 22.04M | 19.13M | 4.29M | 3.15M |
| Property-Plant & Equipment | 2.36M | 3.75M | 3.15M | 4.2M | 4.71M | 948K | 805K | 741K | 259K | 71K | 77K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 9.13M | 6.71M | 5.36M | 6.39M | 53.75M | 1.32M | 1.08M | 1.01M | 259K | 71K | 77K |
| Total Assets | 178.31M | 136.24M | 119.75M | 122M | 202.39M | 103.56M | 75.55M | 23.06M | 19.39M | 4.36M | 3.23M |
| Account Payables | 6.51M | 5.53M | 5.79M | 3.27M | 4.69M | 4.27M | 2.84M | 1.88M | 1.72M | 513K | 334K |
| Deferred Revenue | n/a | 618K | 497K | 382K | n/a | n/a | 650K | n/a | n/a | n/a | n/a |
| Short-Term Debt | n/a | 941K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 24.7M | 17.45M | 16.59M | 18.16M | 14.79M | 9.19M | 3.55M | 1.26M | 521K | 378K | 150K |
| Total Current Liabilities | 31.21M | 23.92M | 22.38M | 21.44M | 19.48M | 13.46M | 7.04M | 3.14M | 2.24M | 891K | 484K |
| Long-Term Debt | 99.39M | 99.12M | 398K | 1.5M | 2.6M | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | 112.92M | 101.94M | 88.56M | 2.72M | n/a | n/a | n/a | 3.61M | 872K | n/a | n/a |
| Total Long-Term Liabilities | 212.31M | 201.06M | 88.95M | 4.21M | 2.6M | n/a | n/a | 3.61M | 872K | n/a | n/a |
| Total Liabilities | 243.52M | 224.98M | 111.33M | 25.65M | 22.09M | 13.46M | 7.04M | 6.75M | 3.11M | 891K | 484K |
| Total Debt | 100.21M | 99.12M | 398K | 1.5M | 2.6M | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock | 89K | 63K | 61K | 60K | 57K | 44K | 37K | 6K | 6K | 2K | 2K |
| Retained Earnings | -679.35M | -577.1M | -467.32M | -356.5M | -228.02M | -122.87M | -47.21M | -27.21M | -25.27M | -12.58M | -8.11M |
| Comprehensive Income | 12K | -107K | -25K | 271K | 276K | -747K | -577K | -370K | -157K | n/a | 0.00 |
| Shareholders Equity | -65.21M | -88.74M | 8.41M | 96.36M | 180.3M | 90.09M | 68.52M | 16.31M | 16.28M | 3.47M | 2.74M |
| Total Investments | 46.47M | 44.56M | 45.45M | 51.05M | 145.94M | 51K | 36M | 24K | n/a | n/a | n/a |